PATENT LICENSE AGREEMENTStock Issuance Agreement • March 14th, 2017 • Kura Oncology, Inc. • Pharmaceutical preparations • Delaware
This Agreement is effective as of December 22, 2014 (the "EFFECTIVE DATE"), between Kura Oncology, Inc. ("LICENSEE") having the address in Article 12 below, and the Regents of the University of Michigan, a constitutional corporation of the state of Michigan ("MICHIGAN"). LICENSEE and MICHIGAN hereby agree as follows:
THIRD AMENDMENT TO SUBLEASESublease • March 14th, 2017 • Kura Oncology, Inc. • Pharmaceutical preparations
THIS THIRD AMENDMENT TO SUBLEASE (this “Third Amendment”) is made as of December 20, 2016, by and between WELLSPRING BIOSCIENCES LLC, a Delaware limited liability company (“Sublessor”), and KURA ONCOLOGY, INC., a Delaware corporation (“Sublessee”).
SUBLEASESublease • March 14th, 2017 • Kura Oncology, Inc. • Pharmaceutical preparations
THIS SUBLEASE (“Sublease”), dated December 20, 2016, for reference purposes only, is entered into by and between WELLSPRING BIOSCIENCES LLC, a Delaware limited liability company (“Sublandlord”), and KURA ONCOLOGY, INC., a Delaware corporation (“Subtenant”).
